Equifax (EFX) Stock Forecast & Price Target

$272.08 +9.21 (+3.50%)

As of 03:59 PM Eastern

Equifax - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
0

Hold
2

Buy
15

Based on 17 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 2 have given a hold rating, and 15 have given a buy rating for EFX.

Consensus Price Target

$311.12
14.35% Upside

According to the 17 analysts' twelve-month price targets for Equifax, the average price target is $311.12. The highest price target for EFX is $380.00, while the lowest price target for EFX is $275.00. The average price target represents a forecasted upside of 14.35% from the current price of $272.08.

Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

EFX Analyst Ratings Over Time

Type	Current Forecast 1/22/24 to 1/21/25	1 Month Ago 12/23/23 to 12/22/24	3 Months Ago 10/24/23 to 10/23/24	1 Year Ago 1/22/23 to 1/22/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	14 Buy rating(s)	16 Buy rating(s)	14 Buy rating(s)
Hold	2 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$311.12	$311.18	$310.47	$257.12
Forecasted Upside	14.35% Upside	20.41% Upside	14.25% Upside	3.47% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Equifax Stock vs. The Competition

Type	Equifax	Business Services Companies	S&P 500
Consensus Rating Score	2.88	2.69	2.52
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	14.35% Upside	753.87% Upside	11.17% Upside
News Sentiment Rating	Neutral News See Recent EFX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/15/2025	Jefferies Financial Group 2 of 5 stars	Surinder Thind Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$340.00 ➝ $300.00	+13.77%
1/10/2025	Wells Fargo & Company 3 of 5 stars	J. Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$325.00 ➝ $321.00	+30.22%
12/16/2024	BNP Paribas 3 of 5 stars	A. Grobler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$305.00	+14.74%
12/12/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Wurtzel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
12/12/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$275.00 ➝ $320.00	+21.79%
11/20/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$305.00 ➝ $284.00	+16.43%
11/19/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$304.00 ➝ $283.00	+16.93%
11/19/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$315.00 ➝ $286.00	+16.60%
10/28/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$350.00 ➝ $350.00	+29.68%
10/18/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$290.00 ➝ $333.00	+18.01%
Get the Latest News and Ratings for EFX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.
10/1/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Mcveigh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$360.00	+22.51%
9/13/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$300.00 ➝ $380.00	+24.12%
8/20/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$277.00 ➝ $307.00	+4.23%
7/24/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$263.00 ➝ $304.00	+15.32%
7/18/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$255.00 ➝ $286.00	+10.34%
2/13/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	In-Line ➝ Outperform	$210.00 ➝ $310.00	+21.21%
2/9/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$270.00 ➝ $285.00	+14.38%
1/11/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$272.00	+11.10%
12/8/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$218.00 ➝ $267.00	+19.05%
11/17/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform
7/21/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$235.00 ➝ $250.00	+15.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 08:23 PM ET.

Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, January 7, 2025. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

Here are some ways that investors could benefit from investing in Equifax Inc.:

Equifax Inc. has a strong dividend yield of 0.59%, providing a steady income stream for investors. The recent dividend of $0.39 per share reflects a commitment to returning value to shareholders.
The company has shown robust financial performance, with a reported earnings per share (EPS) of $1.85, slightly exceeding analysts' expectations. This indicates strong operational efficiency and profitability.
Equifax Inc. has received positive analyst ratings, with a consensus rating of "Moderate Buy" and a price target of $311.67, suggesting potential for price appreciation.
Recent institutional investment activity, such as Franklin Resources Inc. increasing its stake by 34.2%, indicates confidence in the company's future performance and stability.
The current stock price of $265.81 is below the recent high of $309.63, presenting a potential buying opportunity for investors looking for growth.

Equifax
Bear Case

Investors should be bearish about investing in Equifax Inc. for these reasons:

The company's price-to-earnings (P/E) ratio of 59.07 is relatively high, which may indicate that the stock is overvalued compared to its earnings, potentially leading to a price correction.
Equifax Inc. has a debt-to-equity ratio of 0.96, suggesting that the company is using a significant amount of debt to finance its operations, which could pose risks in a rising interest rate environment.
Despite positive earnings, the company's revenue growth of 9.3% year-over-year may not be sufficient to meet the high expectations set by analysts, leading to potential disappointments in future earnings reports.
Recent downgrades in target prices by some analysts, such as JPMorgan Chase & Co. reducing their target from $304.00 to $283.00, may signal a lack of confidence in the stock's short-term performance.
The stock's volatility, indicated by a beta of 1.57, suggests that it may experience larger price swings compared to the overall market, which could be a concern for risk-averse investors.

EFX Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $311.12, with a high forecast of $380.00 and a low forecast of $275.00.
: 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last twelve months. There are currently 2 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" EFX shares.
: According to analysts, Equifax's stock has a predicted upside of 14.35% based on their 12-month stock forecasts.
: Over the previous 90 days, Equifax's stock had 2 upgrades and 1 downgrade by analysts.
: Equifax has been rated by research analysts at BNP Paribas, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Oppenheimer, Stifel Nicolaus, Wells Fargo & Company, and Wolfe Research in the past 90 days.
: Analysts like Equifax more than other "business services" companies. The consensus rating score for Equifax is 2.88 while the average consensus rating score for "business services" companies is 2.69. Learn more on how EFX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:EFX) was last updated on 1/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equifax (EFX) Stock Forecast & Price Target